Otsuka (OTCMKTS:OTSKY) Stock Price Up 8.6% – Still a Buy?

Otsuka Holdings Co., Ltd. – Unsponsored ADR (OTCMKTS:OTSKY)’s share price shot up 8.6% during trading on Tuesday . The stock traded as high as $34.05 and last traded at $34.05. 1,027 shares changed hands during trading, a decline of 97% from the average session volume of 35,667 shares. The stock had previously closed at $31.36.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on the company. UBS Group raised Otsuka to a “hold” rating in a report on Tuesday, January 27th. Zacks Research cut Otsuka from a “hold” rating to a “strong sell” rating in a research report on Monday, March 2nd. The Goldman Sachs Group lowered Otsuka from a “strong-buy” rating to a “strong sell” rating in a research report on Friday, February 27th. Finally, Morgan Stanley upgraded Otsuka to an “overweight” rating in a research note on Friday, January 23rd. One equities research analyst has rated the stock with a Buy rating, one has issued a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Reduce”.

Otsuka Stock Up 3.2%

The business’s fifty day moving average is $30.79 and its 200 day moving average is $28.85.

Otsuka Company Profile

Otsuka Pharmaceutical Co, Ltd., trading in the U.S. under the ticker OTCMKTS:OTSKY, is a global healthcare company headquartered in Tokyo, Japan. The firm’s core activities span the development, manufacturing and marketing of prescription pharmaceuticals, consumer healthcare products and nutraceuticals. Otsuka focuses its research on areas such as neuroscience, cardiovascular and renal therapies, and oncology, aiming to bring innovative treatments to patients worldwide.

Founded in 1964 by Busaburo Otsuka as a subsidiary of the Otsuka Group, the company has grown into a diversified healthcare enterprise over more than five decades.